Published in Blood Weekly, January 16th, 2003
The study was presented at the American Heart Association's scientific sessions 2002 in Chicago.
"Standard therapy with warfarin is cumbersome and requires monitoring of drug and food interactions with frequent blood testing, which can be avoided with enoxaparin," said leading investigator Joshua A. Beckman, MD, director of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.